Search results for: 'dect tech eu'

This report provides a comprehensive analysis of innovations and growth opportunities in the surgical visualization landscape, highlighting the evolution of image-guided navigation, AI-powered image fusion, and immersive visualization platforms. With the increasing traction towards minimally invasive surgeries and multimodal imaging, traditional 2D...

This study focuses on emerging pharmacological and non-pharmacological strategies in the treatment of obesity, as well as evolving new paradigms for the future. It describes the contribution of incretin-based therapies, particularly GLP-1 receptor agonists and their multi-agonist counterparts, which provide robust effects on weight loss and metabol...

The increasing burden of neuropsychiatric conditions on healthcare systems and pharmacotherapy challenges including side effects, limited and delayed efficacy, and non-responsiveness calls for alternative solutions that are effective and easy to use. Neuromodulation devices use electrical or magnetic impulses to stimulate nerve activity. They can b...

This Frost Radar benchmarks companies offering digital pathology solutions for hospitals and laboratories and discusses opportunities in clinical, pharma, CRO, and research applications. Digital pathology solutions cover all aspects of workflow including sample collection and preparation, image acquisition and integrated image storage, and anal...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical devices, digital solutions, immersive technologies, and diagnostics industry. The issue includes advanced medical devices such as hand-held robotic device for neurological interventions, non-surgical birth control ...

The global medical devices industry was valued at $545.38 billion in 2024 and is expected to reach $801.34 billion in 2029. Companies continue to focus on and invest in new product development to ensure long-term and sustained growth. The cardiovascular devices market attracted significant investments, especially in transcatheter technologies for m...

In the rapidly evolving landscape of 2026, where technological advancements are accelerating, the ability to identify, invest in, and leverage these advancements is becoming increasingly critical for organizations aiming to maintain industry leadership and ensure sustainable growth. Recognizing this imperative, Frost & Sullivan introduces (launches...

Biological age tracking is emerging as a complementary approach to understanding human health, offering a more nuanced assessment of physiological state than chronological age alone. This report examines the evolving landscape of biological aging platforms, with a focus on molecular and omics-based technologies including epigenetic, proteomic, tran...

In 2024, the life science (LS) industry s focus on precision health will intensify. LS companies will augment their omics-based research capabilities and increasingly deploy AI and bioinformatics to discover personalized therapies. Partnerships between pharmaceutical companies and technology vendors will multiply, to support innovation in drug disc...